If you need more lookups,
subscriptions start at $34 USD/month.
Michael Shulman Location
San Francisco, CA, US
Michael Shulman Work
Managing Director, Clinical Science and Development Strategy @ (January 2014 - Present)
Owner @ Biomedical Resources for Global Drug Development (January 2004 - Present)
Scientific Advisory Board Member and Consultant @ (January 2001 - Present)
Central Reviewer, Sle @ (March 2012 - March 2016)
Medical Monitor @ (March 2014 - October 2014)
Feasibility Consultant @ (May 2012 - June 2012)
Clinical Consultant, Drug Development and Clinical Trials @ Coyote Pharmaceuticals, Inc. (October 2011 - March 2012)
Consulting Medical Monitor and Safety Officer @ Celtic Pharma (September 2006 - October 2007)
Consultant Medical Monitor and Safety Officer @ Neurobiological Technologies, Inc. (July 2005 - September 2007)
Medical Safety Consultant @ (January 2006 - January 2006)
Drug Safety Consultant @ (May 2004 - June 2005)
u.s. Clinical Consultant @ (June 2003 - November 2003)
Nephrology Consultant @ (March 2002 - August 2002)
Renal Consultant @ Biostratum (August 2000 - September 2001)
Vice President, Clinical Development @ Anergen (January 1997 - March 1999)
Consultant @ Sangstat Medical Corporation (January 1995 - January 1996)
Associate Director, Medical Research, Mycophenolate Mofetil Transplant Program @ Syntex Development Research (February 1994 - December 1994)
Associate Director, Immunohematology and Cardiovascular, Medical Affairs @ (June 1991 - February 1994)
Michael Shulman Education
Columbia University College of Physicians and Surgeons
Doctor Of Medicine (Medicine)
1961-1965
University of North Carolina at Chapel Hill
(Medicine)
1958-1961
Michael Shulman Skills
Clinical Trial Design
CAR-T
Standard of Care
Translational Medicine
Regulatory Requirements
Good Clinical Practice (GCP)
Clinical Research Experience
Pharmaceuticals
Kidney Transplant
Kidney
End Stage Renal Disease
Investments
Mergers & Acquisitions (M&A)
M&A Due Diligence
Deal Sourcing
Business Planning
Regulatory Submissions
Clinical Monitoring
Writing
Respiratory Disease
Cardiovascular Disease
Endocrine Metabolic
Endocrine Metabolic Disorders
Clinical Trials
Medical Writing
Protocol Development
Consulting
Nephrology
Multiple Sclerosis
Hypertension
Neurology
Clinical Research
Data Analysis
Clinical Protocol Development
Clinical Protocols
Biotechnology
Transplant
Autoimmune Disease
Sle
Clinical Study Design
Immunology
Dialysis
Life Sciences
Good Clinical Practice Gcp
Medical Devices
Support
Translational Research
Pharmacovigilance
Bilag Grading
Neuro Oncology
Lifesciences
Protocol
CRO Management
Medicine
Oncology
Clinical Trial
Pharmaceutical Companies
GCP
Clinical Trial Feasibility Assessment
Clinical Development
Drug Development
Pharmaceutics
Transplantation
Diabetes
Clinical Protocol
Due Diligence
Pharmaceutical Industry
Rheumatology
Technology Transfer
Clinical Safety
Medical Affairs
Biomarkers
FDA
Protein Chemistry
IND
Clinical Protocol Review
Biopharmaceuticals
Good Clinical Practice
Michael Shulman Summary
Michael Shulman, based in San Francisco, CA, US, is currently a Managing Director, Clinical Science and Development Strategy at Pharma Capital Partners. Michael Shulman brings experience from previous roles at Biomedical Resources for Global Drug Development, Mountain View Pharmaceuticals, Inc., American Board of Internal Medicine and Pra Health Sciences. Michael Shulman holds a 1961 - 1965 Doctor Of Medicine in Medicine @ Columbia University College of Physicians and Surgeons. With a robust skill set that includes Clinical Trial Design, CAR-T, Standard of Care, Translational Medicine, Regulatory Requirements and more. Michael Shulman has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Michael Shulman?
Find contact details for 700 million professionals.